CFG
CVS icon

Claremont Financial Group’s CVS Health CVS Stock Holding History

Claremont Financial Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$28K Buy
+270
New +$28.4K 0.12% 28

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Claremont Financial Group's CVS Position: Q1 2022 in Review

Claremont Financial Group opened a new position in CVS Health (CVS) in Q1 2022: 270 shares worth $28K. The stake represents 0.12% of the portfolio and ranks #28 among its holdings.

2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

  • Claremont Financial Group held 270 shares of CVS Health worth $28K as of Q1 2022.
  • CVS Health was a new Claremont Financial Group position in Q1 2022.
  • CVS Health made up 0.12% of Claremont Financial Group's portfolio in Q1 2022, its #28 holding.
  • 2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on Claremont Financial Group's 13F filing for Q1 2022, filed 15 Apr 2022.